Borden Ladner Gervais LLP (BLG) announces new partner Graeme BoocockJanuary 21, 2021
Graeme is a Patent Agent who specializes in drafting and prosecuting patent applications in the life sciences, including personalized medicine and antibody technologies. He counsels clients on patenting strategies and assists with managing international portfolios.
Graeme also assists clients with Plant Breeders’ Rights (PBR) applications. He is an amateur plant breeder and recently developed a new Passiflora variety, ‘Pole Star,’ for which a PBR registration is pending.
Prior to joining BLG, Graeme conducted his doctoral research at The Hospital for Sick Children. This culminated in the discovery of the human gene that is mutated in Shwachman-Diamond syndrome. He then worked a post-doctoral researcher at the MRC Laboratory of Molecular Biology in Cambridge, UK, focusing on protein engineering.
To learn more about Graeme, please visit our website.
As the largest, truly full-service Canadian law firm, Borden Ladner Gervais LLP (BLG) delivers practical legal advice for domestic and international clients across more practices and industries than any Canadian firm. With 800 lawyers, intellectual property agents and other professionals, BLG serves the legal needs of businesses and institutions across Canada and beyond – from M&A and capital markets, to disputes, financing, and trademark & patent registration.
Borden Ladner Gervais LLP
Area Of Practice
Registered Canadian Patent Agent and Registered U.S. Patent Agent for Canadian applicants.